Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis

BACKGROUND: In the past decade, fibroblast growth factor 23 (FGF23) has been recognized as an important biomarker of cardiovascular diseases. This study aimed to assess the relationship between FGF23 and the risk of cardiovascular diseases (CVDs) in general populations. METHODS: The protocol was reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Menglu, Xia, Panpan, Tan, Ziqi, Song, Tiangang, Mei, Kaibo, Wang, Jingfeng, Ma, Jianyong, Jiang, Yuan, Zhang, Jing, Zhao, Yujie, Yu, Peng, Liu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669381/
https://www.ncbi.nlm.nih.gov/pubmed/36407457
http://dx.doi.org/10.3389/fcvm.2022.989574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669381/
https://www.ncbi.nlm.nih.gov/pubmed/36407457
http://dx.doi.org/10.3389/fcvm.2022.989574

Ejemplares similares